Equities

Omnicell Inc

Omnicell Inc

Actions
Health CareHealth Care Providers
  • Price (USD)43.42
  • Today's Change0.64 / 1.50%
  • Shares traded1.00
  • 1 Year change-20.85%
  • Beta0.8337
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments490342360
Total Receivables, Net252299241
Total Inventory110148120
Prepaid expenses342929
Other current assets, total416431
Total current assets928882781
Property, plant & equipment, net134132120
Goodwill, net736734739
Intangibles, net278324375
Long term investments433318
Note receivable - long term121518
Other long term assets8.247.469.28
Total assets2,2272,2112,142
LIABILITIES
Accounts payable456372
Accrued expenses188225192
Notes payable/short-term debt000
Current portion long-term debt/capital leases--0488
Other current liabilities, total134140124
Total current liabilities368428876
Total long term debt5705670
Total debt570567488
Deferred income tax1.622.1052
Minority interest------
Other liabilities, total998468
Total liabilities1,0381,081996
SHAREHOLDERS EQUITY
Common stock0.060.060.05
Additional paid-in capital1,1221,0471,025
Retained earnings (accumulated deficit)370391369
Treasury stock - common(290)(290)(238)
Unrealized gain (loss)------
Other equity, total(13)(17)(8.41)
Total equity1,1891,1301,147
Total liabilities & shareholders' equity2,2272,2112,142
Total common shares outstanding464544
Treasury shares - common primary issue10109.89
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.